Skip to main content

Thrombosis: Medical Treatments

Volume 470: debated on Tuesday 15 January 2008

To ask the Secretary of State for Health pursuant to the answer of 26 November 2007, Official Report, column 261W, on thrombosis: medical treatment, what plans he has for the National Institute for Health and Clinical Excellence to assess rivaroxaban for the prevention of venous thromboembolism in patients undergoing major orthopaedic surgery of the lower limbs. (177439)

Rivaroxaban for the prevention of venous thromboembolism after major orthopaedic surgery is currently being considered for referral to the National Institute for Health and Clinical Excellence for appraisal.